Published on 12 Oct 2021 on Benzinga via Yahoo Finance
Ocugen Inc. (NASDAQ: OCGN) shares were trading higher Tuesday after the Indian government approved Bharat Biotech’s COVID-19 vaccine Covaxin, for children between the ages of 2 and 18.
Ocugen is partnered with Bharat Biotech. Other popular COVID-19 vaccine companies unable to keep up with Ocugen’s gains Tuesday include Moderna Inc. (NASDAQ: MRNA), Novavax Inc. (NASDAQ: NVAX), and Vaxart Inc. (NASDAQ: VXRT).